These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7376831)

  • 21. The protein activator specific for the enzymic hydrolysis of GM2 ganglioside in normal human brain and brains of three types of GM2 gangliosidosis.
    Hirabayashi Y; Li YT; Li SC
    J Neurochem; 1983 Jan; 40(1):168-75. PubMed ID: 6848657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of unusual hexosaminidase A (HEX A) deficient human mutants.
    O'Brien JS; Tennant L; Veath ML; Scott CR; Bucknall WE
    Am J Hum Genet; 1978 Nov; 30(6):602-8. PubMed ID: 747188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of 4-methylumbelliferyl-beta-D-N-acetylglucosamine-6-sulfate and its use in classification of GM2 gangliosidosis genotypes.
    Bayleran J; Hechtman P; Saray W
    Clin Chim Acta; 1984 Nov; 143(2):73-89. PubMed ID: 6239713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel Vector Design and Hexosaminidase Variant Enabling Self-Complementary Adeno-Associated Virus for the Treatment of Tay-Sachs Disease.
    Karumuthil-Melethil S; Nagabhushan Kalburgi S; Thompson P; Tropak M; Kaytor MD; Keimel JG; Mark BL; Mahuran D; Walia JS; Gray SJ
    Hum Gene Ther; 2016 Jul; 27(7):509-21. PubMed ID: 27197548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases.
    Huang JQ; Trasler JM; Igdoura S; Michaud J; Hanal N; Gravel RA
    Hum Mol Genet; 1997 Oct; 6(11):1879-85. PubMed ID: 9302266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neural stem cells for disease modeling and evaluation of therapeutics for Tay-Sachs disease.
    Vu M; Li R; Baskfield A; Lu B; Farkhondeh A; Gorshkov K; Motabar O; Beers J; Chen G; Zou J; Espejo-Mojica AJ; Rodríguez-López A; Alméciga-Díaz CJ; Barrera LA; Jiang X; Ory DS; Marugan JJ; Zheng W
    Orphanet J Rare Dis; 2018 Sep; 13(1):152. PubMed ID: 30220252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The specificity of human N-acetyl-beta-D-hexosaminidases towards glycosphincolipids is determined by an activator protein.
    Conzelmann E; Sandhoff K
    Adv Exp Med Biol; 1980; 125():295-306. PubMed ID: 6444774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restoration of the GM2 ganglioside metabolism in bone marrow-derived stromal cells from Tay-Sachs disease animal model.
    Martino S; Cavalieri C; Emiliani C; Dolcetta D; Cusella De Angelis MG; Chigorno V; Severini GM; Sandhoff K; Bordignon C; Sonnino S; Orlacchio A
    Neurochem Res; 2002 Aug; 27(7-8):793-800. PubMed ID: 12374215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2.
    Conzelmann E; Sandhoff K
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3979-83. PubMed ID: 99746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The biochemical genetics of the hexosaminidase system in man.
    Beutler E
    Am J Hum Genet; 1979 Mar; 31(2):95-105. PubMed ID: 377957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In-silico screening and microsecond molecular dynamics simulations to identify single point mutations that destabilize β-hexosaminidase A causing Tay-Sachs disease.
    Almanasra A; Havranek B; Islam SM
    Proteins; 2021 Nov; 89(11):1587-1601. PubMed ID: 34288098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Biosynthesis and biodegradation of GM2 ganglioside].
    Hirabayashi Y; Kasakura H; Matsumoto M
    Tanpakushitsu Kakusan Koso; 1984 Sep; 29(9):708-22. PubMed ID: 6240072
    [No Abstract]   [Full Text] [Related]  

  • 33. Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease.
    Mark BL; Mahuran DJ; Cherney MM; Zhao D; Knapp S; James MN
    J Mol Biol; 2003 Apr; 327(5):1093-109. PubMed ID: 12662933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tay-Sachs disease in Jacob sheep.
    Torres PA; Zeng BJ; Porter BF; Alroy J; Horak F; Horak J; Kolodny EH
    Mol Genet Metab; 2010 Dec; 101(4):357-63. PubMed ID: 20817517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Recent advances in molecular genetics of GM2 gangliosidosis].
    Wakamatsu N
    Nihon Rinsho; 1995 Dec; 53(12):2988-93. PubMed ID: 8577047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prenatal Diagnosis of Tay-Sachs Disease.
    Zhang J; Chen H; Kornreich R; Yu C
    Methods Mol Biol; 2019; 1885():233-250. PubMed ID: 30506202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absence of metabolic cross-correction in Tay-Sachs cells: implications for gene therapy.
    Martino S; Emiliani C; Tancini B; Severini GM; Chigorno V; Bordignon C; Sonnino S; Orlacchio A
    J Biol Chem; 2002 Jun; 277(23):20177-84. PubMed ID: 11923278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tay-Sachs disease and normal cerebellar cells in culture: elevated levels of lysosomal enzymes in Tay-Sachs disease cells.
    Hoffman LM; Brooks SE; Schneck L
    J Neurosci Res; 1982; 8(1):49-55. PubMed ID: 6816949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuronal lysosomal enzyme replacement using fragment C of tetanus toxin.
    Dobrenis K; Joseph A; Rattazzi MC
    Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2297-301. PubMed ID: 1532255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Towards enzyme replacement in GM2 gangliosidosis: organ disposition and induced central nervous system uptake of human beta-hexosaminidase in the cat.
    Rattazzi MC; Lanse SB; McCullough RA; Nester JA; Jacobs EA
    Birth Defects Orig Artic Ser; 1980; 16(1):179-93. PubMed ID: 6778524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.